A61P 19 - Drugs for skeletal disorders

Patents for A61P 19 - Drugs for skeletal disorders (81,981)
10/2007
10/17/2007	EP1284724A4 Method of preparing alkylated salicylamides via a dicarboxylate intermediate
10/17/2007	EP1204649B1 Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents
10/17/2007	EP1153034B1 Growth hormone secretagogues
10/17/2007	EP1084230B1 Regulation of hematopoietic stem cell differentiation by the use of human mesenchymal stem cells
10/17/2007	EP0787122B9 Calcium receptor-active compounds
10/17/2007	CN101056658A Oral preparation having improved bioavailability
10/17/2007	CN101054412A Pathogenic gene for far end arthrosis bend, detection method and application thereof
10/17/2007	CN101054364A Substituted 4-(indazol-3-yl)phenols as estrogen receptor (ER) ligands and their use in the treatmentof inflammarory diseases
10/17/2007	CN101054352A New strontium salts of sulphonic acids, a process for their preparation and pharmaceutical compositions containing them
10/17/2007	CN101054344A Lipoxin A4 analogs
10/17/2007	CN101053644A Traditional Chinese medicinal composition for treating protrusion of the intervertebral disc and preparation method and traditional Chinese medicine preparation
10/17/2007	CN101053633A Medicinal composition for treating rheumatalgia pain
10/17/2007	CN101053618A Ointment for treating hyperplasia carbuncle wound and its preparing process
10/17/2007	CN101053615A Medicinal composition for treating bone fracture and injury and its preparation method
10/17/2007	CN101053614A Flesh and blood healing external applied anti-infectious powder and its medicine preparation
10/17/2007	CN101053609A Black plaster for treating hyperosteogeny and its preparing method
10/17/2007	CN101053608A 'Gushukang' micropills and its preparation technology
10/17/2007	CN101053599A Compound oral preparation composition for treating wound and pain and preparing products method thereof
10/17/2007	CN101053586A Medicinal composition for treating osteoporosis and preparation method thereof
10/17/2007	CN101053561A Methods and compositions useful for inhibition of alpha v beta 5 mediated angiogenesis
10/17/2007	CN101053547A Sterile medlar buds nourishing face pack
10/17/2007	CN100343276C Bone formation stimulant, synthetic method and uses thereof
10/17/2007	CN100343258C Novel 4-amino-5,6-substituted thiopheno 2,3-d]pyrimidines
10/17/2007	CN100343257C CCR1 antagonists for the treatment of I.A. demyelinating inflammatory disease
10/17/2007	CN100342899C Fragrants medicated liquor for treating fractures
10/17/2007	CN100342898C Zhulan medicated liquor
10/17/2007	CN100342897C Chinese-yeast-hops medicated liquor
10/17/2007	CN100342889C Chinese medicine for treating gout
10/17/2007	CN100342886C Medicated liquor of Radix elsholtziae Fruticosae
10/17/2007	CN100342885C Medicated liquor of Herba Tetrastigmae Yunnanensis
10/17/2007	CN100342884C Medicated liquor of Radix Tetrastigmatis Hypoglauci
10/17/2007	CN100342883C Compound essence oil for curing arthralgia and myalgia of human
10/17/2007	CN100342870C Pain-alleviating inflammation-relieving Chinese medicinal plaster for treating osteoporosis
10/17/2007	CN100342866C Tuqiannianjian medicated liquor
10/16/2007	US7282591 1h-benzo{f}indazol-5-yl derivatives as selective glucocorticoid receptor modulators
10/16/2007	US7282512 Such as 1-benzylcyclobutyl (1S)-1-(oxo{[(1R)-1-phenylethyl]amino}acetyl)pentylcarbamate for treatment of osteoporosis
10/16/2007	US7282508 Substituted 4-phenyl-4-(1H-imidazol-2-yl)-piperidine derivatives and their use as selective non-peptide delta opioid agonists
10/16/2007	US7282504 Kinase inhibitors
10/16/2007	US7282502 S,N-diarylsulfonamide derivatives; treating inflammatory diseases such as Celiac's disease, Crohn's disease or colitis; N-(2-Benzoyl-4-chloro-phenyl)-4-chloro-benzenesulfonamide; N-[4-Chloro-2-(pyridin-2-ylsulfanyl)-phenyl]-4-isopropyl-benzenesulfonamide
10/16/2007	US7282496 Rheumatic diseases; bone disorders; Aids; antiinflammatory agents
10/16/2007	US7282490 Osteopontin-related compositions and methods
10/16/2007	US7282206 Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains
10/16/2007	US7282200 Composition of fibroblast or chondrocyte cells transfected or transduced with a gene encoding transforming growth factor beta 1 (TGF- beta 1) or bone morphogenetic protein 2 (BMP-2), and chondrocyte cells that have not been transfected with the gene; generating hyaline cartilage at a target site
10/16/2007	CA2419194C Cyclopentyl modulators of chemokine receptor activity
10/16/2007	CA2414018C 2-aminocarbonyl-9h-purine derivatives
10/16/2007	CA2327253C Sulfonamide-containing indole compounds
10/16/2007	CA2319275C Bicyclic pyridine and pyrimidine derivatives as neuropeptide y receptor antagonists
10/11/2007	WO2007114770A1 Piperidine derivatives useful for treating osteoarthritis and osteoartrosis
10/11/2007	WO2007114697A1 Novel composition for tumor growth control
10/11/2007	WO2007114213A1 Substituted bicyclic cyclic derivative and use thereof
10/11/2007	WO2007112913A2 Benzimidazole derivatives
10/11/2007	WO2007112682A1 Recombinant human parathyroid hormone-related proteins and uses thereof
10/11/2007	WO2007071313A3 Combination of anticholinergics, glucocorticoids, beta2-ag0nists, pde4 inhibitor and antileukotriene for the treatment of inflammatory diseases
10/11/2007	WO2000072801A3 Alpha v integrin receptor antagonists
10/11/2007	US20070238781 Compounds for the modulation of the glykolysis-enzyme-and/or of the transaminase-complex
10/11/2007	US20070238776 Novel Pyrroles Having Hypolipidemic Hypocholesteremic Activities, Process for Their Preparation and Pharmaceutical Compositions Containing Them and Their Use in Medicine
10/11/2007	US20070238769 Bone Densifying Agent Characterized By Use Of Cathepsin K Inhibitor With Pth
10/11/2007	US20070238763 Urea derivatives as integrin a4 antagonists
10/11/2007	US20070238757 Novel treatment
10/11/2007	US20070238741 Hypertension, atherosclerosis, restenosis, cerebral ischemia, cerebral vasospasm, or erectile dysfunction; 2-(5-chloro-2-thienyl)-N-(1H-indazol-5-yl)thieno[3,2-d]pyrimidin-4-amine
10/11/2007	US20070238735 Cyclooxygenase-2 selective inhibitors, compositions and methods of use
10/11/2007	US20070238728 Novel dipeptidyl peptidase iv inhibitors, process for their preparation and compositions containing them
10/11/2007	US20070238693 Genetic modification of the lung as a portal for gene delivery
10/11/2007	US20070238683 Modified and stabilized gdf propeptides and uses thereof
10/11/2007	US20070238677 Pharmaceutical Composition Containing Hshrd3
10/11/2007	US20070237825 Reusable, nonbioadhesive, microporous hydrogel for hydrating and dehydrating dermatological surfaces prepared from hydroxyalkyl (meth)acrylate, a crosslinking agent, water, aliphatic alcohol (isopropanol), and a fibrous filler
10/11/2007	US20070237823 Solid Pharmaceutical Form Comprising and Ltb4 Antagonist
10/11/2007	CA2647986A1 Compositions for tumor growth control
10/11/2007	CA2647811A1 Substituted bicyclic derivative and use thereof
10/11/2007	CA2646086A1 Piperidine derivatives useful for treating osteoarthritis and osteoartrosis
10/11/2007	CA2644380A1 Benzimidazole derivatives
10/10/2007	EP1842918A1 Receptor nucleic acids and polypeptides
10/10/2007	EP1841772A1 Tetrahydrofurane derivatives for use as inhibitors of matrix metalloproteinases
10/10/2007	EP1841454A2 Treatment method
10/10/2007	EP1841441A2 Herbal preparation for joints
10/10/2007	EP1841429A2 Solid forms of a chemokine receptor antagonist and methods of use thereof
10/10/2007	EP1525200B1 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors
10/10/2007	EP1454897B1 Pyrazolopyrimidinone derivatives having pde7-inhibitory activity
10/10/2007	EP1354884B1 Cyclopenta[d]pyrazolo[1,5-a]pyrimidine compound as crf receptor antagonist
10/10/2007	EP1347990B1 Peptides having inhibiting activity to nitric oxyde production
10/10/2007	EP1332132B1 Enamine derivatives as cell adhesion molecules
10/10/2007	EP1319007B9 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
10/10/2007	EP1232150B1 Urea derivatives as anti-inflammatory agents
10/10/2007	CN101052634A Anthranilamide pyridinureas as vegf receptor kinase inhibitors
10/10/2007	CN101052632A Dibenzosuberone derivatives
10/10/2007	CN101052623A Phenanthridine carbonyl phenols as cytokine modulators
10/10/2007	CN101052298A S1-5-containing protein preparation
10/10/2007	CN101049495A Preparation of Chinese traditional medicine for treating scleroderma
10/10/2007	CN101049458A Medicated wine and preparation method
10/10/2007	CN101049457A Composition of Chinese traditional medicine for treating rheumatism
10/10/2007	CN101049451A Application of compound preparation in medication for treating generalized bone fracture, weight reduction, and fighting against senium
10/10/2007	CN101049442A Preparation of Chinese traditional medicine of clearing away heat and promoting diuresis, promoting blood circulation and activating the channels, and preparation method
10/10/2007	CN101049437A External ointment for treating numbness and ache of cold dampness
10/10/2007	CN101049436A Vertigo pill for improving blood circulation at header
10/10/2007	CN101049430A External ointment for treating bone fracture
10/10/2007	CN101049411A Preparation of Chinese traditional medicine for treating scleroderma
10/10/2007	CN101049387A Composition of Chinese traditional medicine for treating rheumatic bone disease
10/10/2007	CN101049369A Medication for treating prolapse of lumbar intervertebral disc
10/10/2007	CN101049360A Preparation of Chinese traditional medicine for treating gout disease, and application of extractive of Chinese feveruine
10/10/2007	CN101049357A Composition for preventing and treating osteoporosis, and preparation method

1 ... 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 ... 820